Medicare Advantage has become one of the most important parts of the American health care system. Designed as a privately administered alternative to traditional Medicare, the program allows insurers to manage coverage for older adults while receiving payments from the federal government. Supporters argue that Medicare Advantage can reduce unnecessary spending while giving seniors access to benefits that traditional Medicare may not fully provide.
Yet recent scrutiny has raised a more complicated question: What happens when cost control begins to limit access to necessary care? A recent federal watchdog report found that Medicare Advantage plans denied a significant share of requests for skilled nursing facility care. These facilities are often used by older patients recovering after major medical events or hospital stays. For many patients, access to this care can shape the quality and speed of recovery.
The most notable finding was not simply that denials occurred. It was that when patients appealed those denials, nearly all were eventually overturned.
This raises an important concern. If many denials are reversed after appeal, the original decision may not always reflect a clear lack of medical necessity. Instead, it may show how administrative barriers can influence access to care.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Prior authorization is intended to prevent wasteful or unnecessary treatment. In theory, this protects both patients and public spending. Health care costs are high, and insurers have a legitimate role in reviewing expensive services.
However, prior authorization also creates friction. Before care is approved, patients and providers often have to submit documentation, wait for a decision, and challenge denials when they occur. Even when care is eventually approved, the process can delay treatment and shift administrative burdens onto people already navigating serious health issues.
This delay has economic consequences. A denial does not need to be final in order to reduce spending. If the process is difficult enough, some patients may never appeal, while others may accept a less appropriate alternative. Providers may also decide that pursuing approval requires too much time and administrative effort. In these cases, delay can function as a form of cost control.
This dynamic is especially important in Medicare Advantage because the program serves older adults, many of whom are managing complex health conditions. Patients recovering from a hospital stay may be poorly positioned to challenge an insurer or navigate a lengthy approval process. As a result, the burden of delay does not fall evenly across the system.
The issue also reflects a broader tension in American health care. Traditional fee-for-service medicine has often been criticized for encouraging excessive care because providers are paid for each service delivered. Medicare Advantage attempts to address that problem by giving private insurers incentives to manage utilization and reduce unnecessary spending. But reducing overuse can create a different risk: underuse.
If insurers are rewarded for controlling costs, they may have incentives to restrict or delay care, even when that care is clinically appropriate. The challenge is finding a balance between preventing waste and protecting access.
For patients, this balance is not theoretical. A delayed skilled nursing facility admission can slow recovery, extend a hospital stay, or place greater pressure on family caregivers. What appears as an administrative decision within an insurance system can become a meaningful disruption in a patient’s recovery.
The debate over Medicare Advantage is therefore not simply about private insurance or government spending. It is about how health care systems distribute decision-making power.
Doctors recommend care, but insurers often decide whether that care will be covered. When decisions are delayed or reversed only after appeal, the approval process itself becomes central to the health care experience.
Medicare Advantage may continue to play a major role in American health care. It may also offer real benefits for many seniors. But its growth makes the structure of prior authorization more important, not less.
A health care system should be able to control unnecessary spending without making medically appropriate care difficult to access. If the process of approval becomes too burdensome, the system risks rationing care through administrative complexity rather than medical judgment.
In that sense, Medicare Advantage reveals a larger problem within American health care: Access is shaped not only by whether care is covered, but by how difficult it is to obtain approval.
Adam Lee is an undergraduate health policy writer.
